2,5-DICHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)PYRIMIDIN-4-AMINE, 95.0%, 10g

4,7-Dibromo-5,6-di-n-octyloxy-2,1,3-benzothiadiazole>98.0%(GC)200mg

4-(2,5-Diaza-bicyclo[2.2.1]hept-2-ylmethyl)-benzonitrile, 1g

1-(3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl)-3-(methylthio)propan-1-amine oxalate, 95.0%, 1g

2-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YLOXY)ACETIC ACID, 95.0%, 1g

Ethyl 2-fluoro-3-nitrobenzoate, 95.0%, 5g

2-[(6-BROMOQUINAZOLIN-4-YL)(ETHYL)AMINO]ETHAN-1-OL, 95%, 250mg

(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid, 25g

tert-Butyl ((3R,5S)-5-methylpyrrolidin-3-yl)carbamate, 95.0%, 100mg

Lithium hexafluoroantimonate, 1g

2-Oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile, 95.0%, 250mg

1-Bromo-4,4,4-trifluorobutane, 98.0%, 100g

METHYL 3-(5-FLUORO-2-METHOXYPHENYL)-3-OXOPROPANOATE, 95.0%, 250mg